BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 15041332)

  • 21. Application of cyclosporine in renal transplantation: experience at the University of Padua.
    Furian L; Baldan N; Rigotti P
    Transplant Proc; 2004 Mar; 36(2 Suppl):148S-151S. PubMed ID: 15041326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporine in pediatric kidney transplantation.
    Pape L; Ehrich JH; Offner G
    Transplant Proc; 2004 Mar; 36(2 Suppl):203S-207S. PubMed ID: 15041337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of cyclosporine on the development of immunosuppressive therapy.
    Haberal M; Emiroglu R; Dalgiç A; Karakayli H; Moray G; Bilgin N
    Transplant Proc; 2004 Mar; 36(2 Suppl):143S-147S. PubMed ID: 15041325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
    Cantarovich D
    J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine.
    Gonzalez Molina M; Morales JM; Marcen R; Campistol JM; Oppenheimer F; Serón D; Gil-Vernet S; Capdevila L; Andrés A; Lampreave I; Del Castillo D; Cabello M; Burgos D; Valdés F; Anaya F; Escuín F; Arias M; Pallardó L; Bustamante J
    Transplant Proc; 2007 Sep; 39(7):2167-9. PubMed ID: 17889126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of renal transplants from pediatric donors <5 yr of age.
    El-Sabrout R; Buch K
    Clin Transplant; 2005 Jun; 19(3):316-20. PubMed ID: 15877791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective study of the effects of cyclosporine in comparison with azathioprine on renal transplant recipients infected with hepatitis C virus.
    Ichikawa Y; Kishikawa H; Nishimura K; Tokugawa S; Yoshioka I; Arichi N; Fujii N; Kyo M; Nishikawa M
    Transplant Proc; 2006 Dec; 38(10):3451-3. PubMed ID: 17175300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the immunosuppressive treatment on long-term renal graft survival.
    González Molina M; Sola E; Cabello M; García C; Luna E; Rodriguez Algarra G
    Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii52-6. PubMed ID: 15192137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results of kidney transplantation with cyclosporine- and everolimus-based immunosuppression.
    Iaria G; Pisani F; Iorio B; Lucchesi C; De Luca L; Ielpo B; D'Andria D; Tariciotti L; Tisone G
    Transplant Proc; 2006 May; 38(4):1018-9. PubMed ID: 16757249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
    El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA
    Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
    Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
    Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study.
    Opelz G
    Kidney Int Suppl; 1995 Dec; 52():S89-92. PubMed ID: 8587292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From cyclosporine to the future.
    Ponticelli C; Tarantino A; Campise M; Montagnino G; Aroldi A; Passerini P
    Transplant Proc; 2004 Mar; 36(2 Suppl):557S-560S. PubMed ID: 15041405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppression in kidney transplantation in Poland.
    Paczek L; Lao M; Durlik M; Szmidt J; Rowinski W
    Transplant Proc; 2004 Mar; 36(2 Suppl):173S-176S. PubMed ID: 15041331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols.
    Attallah N; Goggins M; Nori U; Abouljoud M; Zasuwa G; Venkat KK; Parasuraman R
    Transplant Proc; 2005 Jun; 37(5):2060-2. PubMed ID: 15964338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pediatric renal transplantation: clinical analysis of 23 cases].
    Chen JH; Shen W; He Q; Jiang R; Peng WH
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1100-3. PubMed ID: 15498295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporine withdrawal improves long-term graft survival in renal transplantation.
    Gallagher M; Jardine M; Perkovic V; Cass A; McDonald S; Petrie J; Eris J
    Transplantation; 2009 Jun; 87(12):1877-83. PubMed ID: 19543068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.